Literature DB >> 18283402

Role of endotoxin in the pathogenesis of critical illness polyneuropathy.

B Mohammadi1, I Schedel, K Graf, A Teiwes, H Hecker, B Haameijer, D Scheinichen, S Piepenbrock, R Dengler, J Bufler.   

Abstract

Critical illness polyneuropathy (CIP) occurs in association with sepsis and multiple organ failure; however, little is known about the pathomechanisms of CIP and its therapy. In order to determine the parameters which interfere with development of CIP, electrophysiological investigations of peripheral nerves and biochemical measures were correlated to each other. The present study includes 20 consecutive patients in an intensive care unit developing severe sepsis or septic shock. Nerve conduction studies and electromyography were performed with occurring sepsis (day 1, 7, 14) and neurophysiological parameters were correlated with biochemical measures, especially indicators of infection and inflammation. It was found that all patients developed neurophysiological signs of axonal motor polyneuropathy. There was a significant correlation between serum concentrations of endotoxin and interleukin-2 receptors (IL2-R) and reduction of the amplitude of the compound motor action potentials. Other clinical and biochemical parameters showed no significant correlations with neurophysiological data. This finding apparently indicates that endotoxin damages nerve axons directly or indirectly, e.g. by activation of inflammatory cascades (IL2-R). Endotoxin appears to be an essential factor in the pathogenesis of CIP in sepsis, and therapeutic options neutralizing endotoxin may prevent development of CIP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18283402     DOI: 10.1007/s00415-008-0722-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

Review 1.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 2.  Warner-Lambert/Parke-Davis award lecture. Cytokine-mediated activation of vascular endothelium. Physiology and pathology.

Authors:  J S Pober
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

Review 3.  Neuromuscular sequelae of critical illness.

Authors:  Nicola Latronico; Indrit Shehu; Elisa Seghelini
Journal:  Curr Opin Crit Care       Date:  2005-08       Impact factor: 3.687

4.  Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons.

Authors:  J Schwarz; J Planck; J Briegel; A Straube
Journal:  Muscle Nerve       Date:  1997-06       Impact factor: 3.217

5.  Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis.

Authors:  M Mohr; L Englisch; A Roth; H Burchardi; S Zielmann
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

6.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure.

Authors:  D W Zochodne; C F Bolton; G A Wells; J J Gilbert; A F Hahn; J D Brown; W A Sibbald
Journal:  Brain       Date:  1987-08       Impact factor: 13.501

7.  Critical illness polyneuromyopathy after artificial respiration.

Authors:  A A Op de Coul; G A Verheul; A C Leyten; R L Schellens; J L Teepen
Journal:  Clin Neurol Neurosurg       Date:  1991       Impact factor: 1.876

8.  Critical illness polyneuromyopathy: the electrophysiological components of a complex entity.

Authors:  Josef Bednarik; Zdenek Lukas; Petr Vondracek
Journal:  Intensive Care Med       Date:  2003-07-17       Impact factor: 17.440

9.  Acute respiratory failure neuropathy: a variant of critical illness polyneuropathy.

Authors:  K C Gorson; A H Ropper
Journal:  Crit Care Med       Date:  1993-02       Impact factor: 7.598

10.  Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins.

Authors:  G Behre; I Schedel; B Nentwig; B Wörmann; M Essink; W Hiddemann
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

View more
  4 in total

1.  The role of endotoxin in critical illness myopathy and polyneuropathy.

Authors:  Jörg Ahrens; Martin Leuwer; Nilufar Foadi; Gertrud Haeseler
Journal:  J Neurol       Date:  2009-03-22       Impact factor: 4.849

2.  Modulation of the main porcine enteric neuropeptides by a single low-dose of lipopolysaccharide (LPS) Salmonella Enteritidis.

Authors:  Anita Mikołajczyk; Sławomir Gonkowski; Dagmara Złotkowska
Journal:  Gut Pathog       Date:  2017-12-12       Impact factor: 4.181

Review 3.  Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19.

Authors:  Madu N Soares; Moritz Eggelbusch; Elie Naddaf; Karin H L Gerrits; Marike van der Schaaf; Bram van den Borst; W Joost Wiersinga; Michele van Vugt; Peter J M Weijs; Andrew J Murray; Rob C I Wüst
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-07       Impact factor: 12.910

4.  No association between systemic complement activation and intensive care unit-acquired weakness.

Authors:  Esther Witteveen; Luuk Wieske; Friso M de Beer; Nicole P Juffermans; Camiel Verhamme; Marcus J Schultz; Ivo N van Schaik; Janneke Horn
Journal:  Ann Transl Med       Date:  2018-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.